Opportunity Information: Apply for RFA OD 10 002
Apply for RFA OD 10 002
- The National Institutes of Health in the health recovery act sector is offering a public funding opportunity titled "ARRAOS Recovery Act Limited Competition Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research Pilot Research (RC4)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.701 Trans NIH Recovery Act Research Support.
- This funding opportunity was created on Jan 20, 2010 and posted on Dec 28, 2009.
- Applicants must submit their applications by Mar 19, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $5,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education State governments Public housing authorities/Indian housing authorities Independent school districts For profit organizations other than small businesses Native American tribal governments (Federally recognized) Special district governments Native American tribal organizations (other than Federally recognized tribal governments) County governments Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses City or township governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "ARRAOS Recovery Act Limited Competition Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research Pilot Research (RC4)" was a National Institutes of Health (NIH) funding announcement supported by American Recovery and Reinvestment Act of 2009 (ARRA) funds, with involvement from both NIH and the Agency for Healthcare Research and Quality (AHRQ). Its central goal was to fund pilot-scale research testing whether behavioral economics strategies, often described as "nudges," can increase how quickly and consistently health care providers adopt findings from comparative effectiveness research (CER) in real clinical practice. Rather than seeking large definitive clinical trials, the announcement emphasized well-designed preliminary or large pilot studies that could demonstrate feasibility, generate strong early evidence, and set up future, more confirmatory research.
The problem this opportunity was trying to address is that even when CER identifies one treatment, procedure, or approach as superior, real-world clinician and health system behavior does not always change very much. In other words, simply publishing evidence or disseminating guidelines often produces a surprisingly modest shift in practice patterns. This FOA encouraged applicants to tackle that implementation gap by using principles from behavioral economics, an interdisciplinary field that blends economics with insights from psychology, decision science, and related social sciences. Behavioral economics is grounded in the idea that people do not make decisions in purely rational, expected-utility ways; instead, choices are influenced by framing, defaults, mental shortcuts, social norms, present bias, loss aversion, and other predictable patterns documented in classic work such as Prospect Theory. The expectation was that interventions informed by these patterns could be designed to fit the realities of clinical workflow and decision-making, ultimately leading to better uptake of evidence-based care.
Projects under this FOA were expected to examine whether behavioral economics-based approaches could do two related things: first, increase adoption of CER-supported practices by clinicians and provider organizations; and second, help sustain or maintain those improved practices over time within patient populations. The emphasis on maintenance matters because short-lived changes may not translate into meaningful improvements in outcomes or system performance. Another theme built into the announcement was practical value and cost effectiveness. The FOA explicitly noted that some nudges might be far cheaper and more scalable than common alternatives such as pay-for-performance (P4P) programs, while still improving adherence to superior evidence-based options. In that sense, the opportunity positioned behavioral economics as a potentially high-leverage tool for implementation science and health system improvement.
The announcement aligned its definition of comparative effectiveness research with the Federal Coordinating Council for CER, pointing applicants to the federal definition used at the time. That framing underscored that the funded studies were not meant to invent entirely new treatments; instead, they were meant to improve the translation of already-available CER findings into routine care. Applicants would likely have been expected to focus on provider behavior, clinical decision processes, and the health system environments where those decisions are made, rather than only on patient education alone. While the FOA text is broad, the "nudging" language implies interventions such as redesigning choice architecture in clinical settings, adjusting defaults in ordering systems, using peer comparison or social norm feedback, changing how information is framed at the moment of decision, or reducing friction costs that prevent clinicians from acting on the best evidence.
Administratively, this was a discretionary grant opportunity using the NIH RC4 mechanism and categorized under Health, tied to Recovery Act research support. The Funding Opportunity Number was RFA-OD-10-002. It was posted on December 28, 2009, with an application closing date of March 19, 2010, and an archive date of April 19, 2010, reflecting its time-limited ARRA context. The estimated total funding amount was $5,000,000, and the award ceiling was $500,000 per award. There was no cost-sharing or matching requirement, which is typical of many NIH opportunities and lowers barriers for applicants who may not have access to non-federal matching funds.
Eligibility was broad and included many types of organizations across the public, nonprofit, academic, and private sectors. Eligible applicants listed included public and private institutions of higher education; nonprofits with or without 501(c)(3) status (with certain distinctions); for-profit organizations other than small businesses as well as small businesses; state, county, city or township, special district governments; independent school districts; public housing authorities/Indian housing authorities; federally recognized tribal governments and other tribal organizations; and U.S. territories or possessions. Additional categories explicitly mentioned included historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, faith-based or community-based organizations, regional organizations, and eligible federal agencies. Overall, the eligibility language signaled a desire to attract a wide range of applicants with access to real clinical environments, data, and implementation settings where provider behavior could be observed and influenced.
In practical terms, the opportunity can be read as a targeted ARRA-era push to improve the return on investment of comparative effectiveness research by ensuring that evidence does not stop at publication, but actually changes care delivery. By funding behavioral economics-informed pilot studies, NIH and AHRQ were effectively encouraging researchers to test scalable, real-world implementation tactics that account for how clinicians actually make decisions under time pressure, uncertainty, and institutional constraints. The intended outcome was a stronger understanding of what drives adoption of CER findings and, ultimately, measurable improvements in the quality of health care in the United States.
FAQs: ARRAOS Recovery Act Limited Competition Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research Pilot Research (RC4)
What is this grant opportunity?
This was an NIH funding opportunity titled "ARRAOS Recovery Act Limited Competition Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research Pilot Research (RC4)." It supported pilot-scale research on using behavioral economics "nudges" to improve how quickly and consistently comparative effectiveness research (CER) findings are adopted in real clinical practice.
Which agencies were involved?
The funding announcement was issued through the National Institutes of Health (NIH) and involved the Agency for Healthcare Research and Quality (AHRQ). It was supported by American Recovery and Reinvestment Act of 2009 (ARRA) funds.
What problem was the program trying to solve?
The program aimed to address the implementation gap: even when CER shows one treatment or approach is better, clinician and health system behavior often changes only modestly. Publishing evidence or disseminating guidelines alone may not meaningfully shift practice patterns.
What was the main goal of the funded projects?
The central goal was to fund pilot research testing whether behavioral economics strategies can increase the adoption of CER-supported practices by clinicians and provider organizations in real-world care settings.
Was the focus on large clinical trials?
No. The announcement emphasized well-designed preliminary studies or large pilot studies. The intent was to demonstrate feasibility, generate strong early evidence, and lay the groundwork for later confirmatory research rather than conduct large definitive clinical trials under this program.
What does "behavioral economics" mean in this context?
Behavioral economics is described as an interdisciplinary field blending economics with psychology, decision science, and related social sciences. It assumes decisions are not purely rational; they are shaped by predictable patterns such as framing effects, defaults, mental shortcuts, social norms, present bias, and loss aversion (often associated with work like Prospect Theory).
What is meant by "nudging" in health care implementation?
"Nudging" refers to designing the choice environment (choice architecture) so that the evidence-based option is easier or more likely to be chosen, without relying solely on traditional approaches like broad education campaigns. In clinical contexts, this could mean changing how choices are presented at the moment decisions are made.
What kinds of interventions were implied by the FOA?
While the description was broad, it implied interventions such as redesigning choice architecture in clinical settings, adjusting defaults in ordering systems, using peer comparison or social norm feedback, changing how information is framed at the moment of decision, or reducing friction costs that keep clinicians from acting on the best evidence.
What outcomes were projects expected to examine?
Projects were expected to examine whether behavioral economics-based approaches could (1) increase adoption of CER-supported practices and (2) help sustain or maintain improved practices over time within patient populations.
Why did the opportunity emphasize sustaining changes over time?
The FOA highlighted that short-lived improvements may not translate into meaningful long-term benefits in outcomes or system performance. Maintenance of improved practices was therefore a key theme.
How did the program define or frame comparative effectiveness research (CER)?
The announcement aligned its CER definition with the Federal Coordinating Council for CER and referenced the federal definition used at the time. The intent was to improve translation of existing CER findings into routine care, not to invent entirely new treatments.
Did the opportunity focus more on providers and health systems or on patients?
Based on the description, it primarily targeted provider behavior, clinical decision processes, and the health system environments where decisions occur. The framing suggests projects were expected to go beyond patient education alone and focus on implementation within clinical workflows.
Why did the FOA mention cost effectiveness and scalability?
The opportunity positioned nudges as potentially less expensive and more scalable than common alternatives such as pay-for-performance (P4P) programs, while still improving adherence to evidence-based options.
What grant mechanism was used?
This was a discretionary grant opportunity using the NIH RC4 mechanism and categorized under Health, tied to Recovery Act research support.
What was the funding opportunity number?
The Funding Opportunity Number was RFA-OD-10-002.
When was the opportunity posted and when did it close?
It was posted on December 28, 2009. The application closing date was March 19, 2010. The archive date was April 19, 2010, reflecting that it was time-limited in the ARRA context.
How much total funding was available?
The estimated total funding amount was $5,000,000.
What was the maximum award size?
The award ceiling was $500,000 per award.
Was cost sharing or matching required?
No. The opportunity stated there was no cost-sharing or matching requirement.
Who was eligible to apply?
Eligibility was broad and included many organization types across public, nonprofit, academic, and private sectors. Eligible applicants included: public and private institutions of higher education; nonprofits with or without 501(c)(3) status (with certain distinctions); for-profit organizations (including small businesses and for-profits other than small businesses); state, county, city or township, and special district governments; independent school districts; public housing authorities/Indian housing authorities; federally recognized tribal governments and other tribal organizations; and U.S. territories or possessions.
Were specific institution types explicitly encouraged or listed?
Yes. The eligibility language explicitly mentioned historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, faith-based or community-based organizations, regional organizations, and eligible federal agencies.
What kinds of settings or capabilities would applicants likely need?
The description signals interest in applicants with access to real clinical environments, relevant data, and implementation settings where provider behavior could be observed and influenced.
How does this opportunity relate to the Recovery Act (ARRA)?
This was an ARRA-supported, time-limited funding initiative intended to accelerate practical improvements in health care delivery by increasing the real-world impact and return on investment of CER.
What was the intended broader impact?
By funding behavioral economics-informed pilot studies, NIH and AHRQ aimed to identify scalable implementation tactics that account for how clinicians make decisions under time pressure, uncertainty, and institutional constraints, ultimately improving uptake of evidence-based care and health care quality in the United States.
Browse more opportunities from the same category: Health Recovery Act
Next opportunity: Recovery Act Limited Competition Comparative Effectiveness Research on Upper Endoscopy in Gastroesophageal Reflux Disease, Eradication Methods for Methicillin Resistant Staphylococcus aureus and Dementia Detection and Management Strategies (RC4)
Previous opportunity: ARRAOS Recovery Act Limited Competition Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research Clinical Trials (RC4)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA OD 10 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA OD 10 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Recovery Act Limited Competition Comparative Effectiveness Research on Upper Endoscopy in Gastroesophageal Reflux Disease, Eradication Methods for Methicillin Resistant Staphylococcus aureus and Dementia Detection and Management Strategies (RC4) Apply for RFA OD 10 008 Funding Number: RFA OD 10 008 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: $500,000 |
| Recovery Act Limited Competition NIH Directors Opportunity for Research in Five Thematic Areas (RC4) Apply for RFA OD 10 005 Funding Number: RFA OD 10 005 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: Case Dependent |
| Recovery Act Limited Competition Methodology Development in Comparative Effectiveness Research (RC4) Apply for RFA OD 10 009 Funding Number: RFA OD 10 009 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: $500,000 |
| Recovery Act Limited Competition Research On Biosamples From Selected Diabetes Clinical Studies (RC4) Apply for RFA OD 10 010 Funding Number: RFA OD 10 010 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: Case Dependent |
| ARRA OS Recovery Act 2009 Accelerating Adoption of Comparative Effectiveness Research Results by Providers and Patients (R18) Apply for RFA AE 10 001 Funding Number: RFA AE 10 001 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: Case Dependent |
| Recovery Act Limited Competition Institutional Comparative Effectiveness Research Mentored Career Development Award (KM1) Apply for RFA OD 10 011 Funding Number: RFA OD 10 011 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: Case Dependent |
| ARRA OS Recovery Act 2009 Limited Competition Enhanced Registries for Quality Improvement and Comparative Effectiveness Research (R01) Apply for RFA HS 10 020 Funding Number: RFA HS 10 020 Agency: Agency for Health Care Research and Quality Category: Health Recovery Act Funding Amount: $4,000,000 |
| Recovery Act Limited Competition Framework Programs for Global Health Signature Innovations Initiative (R24) Apply for RFA OD 10 007 Funding Number: RFA OD 10 007 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: $250,000 |
| Recovery Act Limited Competition Program to Enhance NIH supported Global Health Research Involving Human Subjects (S07) Apply for RFA OD 10 006 Funding Number: RFA OD 10 006 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: $50,000 |
| ARRA OS Recovery Act 2009 Limited Competition Accelerating Implementation of Comparative Effectiveness Findings on Clinical and Delivery System Interventions by Leveraging AHRQ Networks (R18) Apply for RFA HS 10 014 Funding Number: RFA HS 10 014 Agency: Agency for Health Care Research and Quality Category: Health Recovery Act Funding Amount: $16,660,000 |
| ARRA OS Recovery Act 2009 Limited Competition Comparative Effectiveness Delivery System Evaluation Grants (R01) Apply for RFA HS 10 012 Funding Number: RFA HS 10 012 Agency: Agency for Health Care Research and Quality Category: Health Recovery Act Funding Amount: $500,000 |
| ARRA OS Recovery Act 2009 Limited Competition Comparative Effectiveness Delivery System Demonstration Grants (R18) Apply for RFA HS 10 013 Funding Number: RFA HS 10 013 Agency: Agency for Health Care Research and Quality Category: Health Recovery Act Funding Amount: Case Dependent |
| ARRA OS Recovery Act 2009 Limited Competition Enhanced State Data for Analysis and Tracking of Comparative Effectiveness Impact Improved Clinical Content and Race Ethnicity Data (R01) Apply for RFA HS 10 010 Funding Number: RFA HS 10 010 Agency: Agency for Health Care Research and Quality Category: Health Recovery Act Funding Amount: Case Dependent |
| Recovery Act Limited Competition The NIH Directors ARRA Funded Pathfinder Award to Promote Diversity in the Scientific Workforce (DP4) Apply for RFA OD 10 013 Funding Number: RFA OD 10 013 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: $2,000,000 |
| 2010 ARRA Prevention and Wellness Leveraging National Organizations Apply for OS PAW 10 001 Funding Number: OS PAW 10 001 Agency: Office of the Assistant Secretary for Health Category: Health Recovery Act Funding Amount: $1,500,000 |
| ARRA Training in Primary Care Medicine Interdisciplinary and Interprofessional Joint Graduate Degree Apply for HRSA 10 236 Funding Number: HRSA 10 236 Agency: Health Resources and Services Administration Category: Health Recovery Act Funding Amount: Case Dependent |
| ARRA Training in Primary Care Medicine Physician Assistant Training in Primary Care Apply for HRSA 10 234 Funding Number: HRSA 10 234 Agency: Health Resources and Services Administration Category: Health Recovery Act Funding Amount: Case Dependent |
| ARRA Training in Primary Care Medicine Predoctoral Training in Primary Care Apply for HRSA 10 233 Funding Number: HRSA 10 233 Agency: Health Resources and Services Administration Category: Health Recovery Act Funding Amount: Case Dependent |
| ARRA Training in Primary Care Medicine Physician Faculty Development in Primary Ca Apply for HRSA 10 232 Funding Number: HRSA 10 232 Agency: Health Resources and Services Administration Category: Health Recovery Act Funding Amount: Case Dependent |
| ARRA Training in Primary Care Medicine Administrative Academic Units in Primary Care Apply for HRSA 10 231 Funding Number: HRSA 10 231 Agency: Health Resources and Services Administration Category: Health Recovery Act Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA OD 10 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
